Here is the paper on ADE:
– These findings suggest that the production of antibodies against SARS-CoV-2 infectivity-enhancing site could be considered as a possible exacerbating factors for COVID-19 and that a spike protein lacking such antibody epitopes may be required for safe vaccine development, especially for individuals with pre-existing enhancing antibodies.
Roland Baker, Molecular Genetics, U.C. Berkeley Alumnus:
– “Well I’m terrified now.”
Twitter @RolandBakerIII, 20 hours ago.